Syngene International Syngene International, a subsidiary of Biocon, reported 11% year-on-year increase in its first quarter revenue from operations to Rs 875 crore, while net profit for the period surged 59% to Rs 87 crore.A top company official attributed it to continued conversion of pilot programs into longer-term contracts within the firm's research services business."In our biologics manufacturing division, we have seen good progress with the start of operations at the Unit III facility in Bengaluru and in advancing preparations to commence operations at our Bayview facility in the US later this year," Peter Bains, Managing Director and CEO, Syngene International said in a statement."We continued to strengthen and expand our scientific platform capabilities, bringing online a state-of-the-art, dedicated peptide laboratory.While we remain mindful of ongoing macroeconomic factors, we maintain a confident outlook."The company's operating EBITDA margins during the quarter was about 24% driven by revenue growth and a focus on cost optimization."The current quarter's PAT includes a tax benefit arising from transfer of gratuity funds to Employee Gratuity Trust," said Deepak Jain, Chief Financial Officer."We continue to maintain a robust balance sheet enabling us to invest in technology and capabilities to strengthen our customer offerings.While keeping a close watch on market trends, we remain on course to deliver in line with our stated guidance for the year," he added.(You can now subscribe to our ETMarkets WhatsApp channel) READ MORE NEWS ON SyngeneInternationalBioconSyngene InternationalBioconRevenue GrowthNet Profit SurgeQ1Financial ResultsBiologics Manufacturing (What's moving Sensex and Nifty Track latest market news, stock tips, Budget 2025, Share Market on Budget 2025 and expert advice, on ETMarkets.Also, ETMarkets.com is now on Telegram.For fastest news alerts on financial markets, investment strategies and stocks alerts, subscribe to our Telegram feeds .)Subscriband Sensex Today.Top Trending Stocks: SBI Share Price, Axis Bank Share Price, HDFC Bank Share Price, Infosys Share Price, Wipro Share Price, NTPC Share Price ...more